-Lactam - -lactamase inhibitor combinations as the choice therapy for multidrug resistant Acinetobacter
نویسندگان
چکیده
منابع مشابه
Optimal Therapy for Multidrug-Resistant Acinetobacter baumannii
1. Bányai K, Meleg E, Moschidou P, Martella V. Detection of newly described astrovirus MLB1 in stool samples from children [letter]. Emerg Infect Dis. 2010;16:169. 2. Walter JE. Genetic characterization of astroviruses associated with diarrhea among children in a periurban community of Mexico City, 2002 [doctoral dissertation]. Pecs (Hungary): Medical School, University of Pecs. 3. Finkbeiner S...
متن کاملMultidrug-Resistant Acinetobacter baumannii
To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and define individual risk factors for multidrug resistance, we used epidemiologic methods, performed organism typing by pulsed-field gel electrophoresis (PFGE), and conducted a matched case-control retrospective study. We investigated 118 patients, on 27 wards in Israel, in whom MDR A. baumannii was isolated fr...
متن کاملMultidrug-Resistant Acinetobacter baumannii
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 6, June 2007 943 single-source exposure with C. botulinum type B in at least 3 IDUs; this implies that the heroin was obtained from a common source, where contamination with C. botulinum spores may have been introduced when mixed with adulterants or diluted with substances such as dextrose or dyed paper. Skin popping (subcutaneous an...
متن کاملMultidrug-resistant Acinetobacter baumannii, Russia
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 4, April 2007 669 levels of susceptibility because the MIC50 was only 1 dilution below the current breakpoint (7,8). Aztreonam resistance could not be transferred by conjugation between IMP-1–producing (aztreonam-resistant) P. putida and P. aeruginosa (2) and is not associated with a transposon carrying blaVIM-2 (6). No evidence of e...
متن کاملComparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
BACKGROUND & OBJECTIVE Currently, the use of beta-lactamase inhibitors in combination with beta-lactam antibiotics represents an effective measure to combat a specific resistance mechanism of beta-lactamase producing organisms. Knowledge about the susceptibility profile of bacteria to different combination agents available is essential to guide appropriate treatment of severe infections in hosp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: African Journal of Microbiology Research
سال: 2015
ISSN: 1996-0808
DOI: 10.5897/ajmr2014.6840